Latest News

May 1, 2013 10:20 PM
Tocagen Continues To Make Progress On Its Innovative Brain Cancer Therapy

Accelerate Brain Cancer Cure was the first non-profit to fund Tocagen's virally-based drug delivery and treatment system for brain cancer.

April 15, 2013 10:39 AM
From Biotech Entrepreneur to Venture Philanthropy

Max Wallace, CEO of Accelerate Brain Cancer Cure, is a sought-after speaker at biotechnology conferences focusing on new approaches to funding treatments of the world’s most challenging diseases.

April 2, 2013 10:00 AM
White House Announces BRAIN Initiative

The BRAIN Initiative Challenges Researchers to Unlock Mysteries of Human Mind.

February 20, 2013 02:32 PM
Improving The Lives Of Those Affected By Brain Tumors

Ashley Varner guest blogs about her social work pilot study on the lived experience of family members who live with someone diagnosed with a primary malignant brain tumor.

February 1, 2013 06:12 PM
Low Grade Glioma Research Workshop

In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.

January 31, 2013 08:48 PM
ABC2-Funded Research Featured in Scientific American

The collaboration between academic and industry researchers aims to develop a test to detect genetic brain tumor mutations in cerebral spinal fluid and blood.   

January 29, 2013 06:41 PM
Into Fearless, Uncharted Territory: The Brain Cancer Expedition

Max Wallace, CEO of Accelerate Brain Cancer Cure, guest blogs for The Case Foundation about our new project that could revolutionize treatment for patients.

December 17, 2012 07:19 PM
Josh Sommer Named To Forbes' "30 Under 30" List

Josh Sommer is the founder of the Chordoma Foundation.  He is a good friend and we work closely with his organization on a variety of rare disease initiatives.

December 17, 2012 03:06 PM
A Tribute to Anne Feeley

Anne will always be remembered for her kind smile, wonderful sense of humor and determination to make this world a better place.

December 5, 2012 12:05 AM
Max Wallace To Speak At Dupont Summit

Max will join a panel of R&D experts to discuss "The Evolving Research Enterprise:  The Role of Foundations and Strategic Funding."

November 25, 2012 03:31 PM
Avastin Update - November, 2012

Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.

November 15, 2012 10:12 PM
ABC2 Science Salons

A Unique Opportunity To Learn About The Most Innovative New Trends In Brain Tumor Research.

November 1, 2012 03:48 PM
2012 Annual Scientific Gathering

A blog post from Max Wallace, CEO of Accelerate Brain Cancer Cure.

October 29, 2012 04:03 PM
ABC2 Is A "Power Player" Says Xconomy

Max Wallace, CEO of Accelerate Brain Cancer Cure, is featured this week in the leading innovation economy publication, Xconomy.

October 25, 2012 04:44 PM
U.Va. Cancer Initiative Invests $300,000 in Public-Private Research Partnerships

The projects were selected by a review committee, which includes Max Wallace, CEO of Accelerate Brain Cancer Cure.

August 20, 2012 08:59 PM
ABC2 Fellows Program

We are pleased to launch our Fellows program for young scientific investigators.  They will examine business development and strategy issues within pharmaceutical, biotechnology, financial and philanthropic organizations.

August 10, 2012 02:31 PM
Avastin Update

Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin study by Genentech.

August 2, 2012 05:09 PM
Study suggests new treatment target for deadly brain tumors

Scientists led by Dr. Luis Parada at UT Southwestern Medical Center have identified a cancer stem cell-like treatment target against glioblastoma (GBM) - the most deadly type of brain tumor.

July 30, 2012 03:44 PM
Research May Lead to New Treatment for Glioblastoma Brain Tumor

The study, led by Antonio Iavarone at Columbia University Medical Center, pinpoints a genetic cause of some cases of glioblastoma (GBM) -- the most lethal form of brain tumor.

July 26, 2012 06:46 PM
Vanderbilt-led team to develop 'microbrain' to improve drug testing

The research is part of the National Institute of Health's $70 million "Tissue Chip For Drug Testing" program.

June 21, 2012 12:18 PM
Subtype of Glioblastoma Multiforme (GBM) Is Associated With Longer Life Expectancy

University of Wisconsin-Madison research shows new prognosis tool for deadly brain cancer.

June 15, 2012 12:03 PM
Researchers Determine Pathway for Origin of Most Common Form of Brain and Spinal Cord Tumor

Johns Hopkins scientists hope discovery will drive drug treatments for meningioma brain tumors

June 7, 2012 01:44 PM
Canadian "Dream Team" To Tackle Deadly Brain Cancer

A multi-partner, $8.2 million investment will develop new glioblastoma treatments.

June 7, 2012 12:12 PM
NIH study finds childhood CT scans linked to leukemia and brain cancer later in life

Overall risk is low and outweighed by the reason the child needs the CT scan in the first place.

June 4, 2012 01:54 PM
Wisconsin Team Reveals Way to Treat Drug-resistant Brain Tumor Cells

New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies.

 


 

Pages

Share |

Join us in our fight for a cure!

Twitter